ArticleBioMed research international2026
The Effects of Neonatal Zingerone Administration and Adolescent Alcohol Exposure on Bone Health Markers and Morphometry in Male Sprague-Dawley Rats.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Effects of Neonatal Zingerone Administration and Adolescent Alcohol Exposure on Bone Health Markers and Morphometry in Male Sprague-Dawley Rats.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveNeonatal interventions influence long-term developmental outcomes, with excessive alcohol consumption impairing metabolism and bone health. Zingerone, a natural antioxidant, may possess health benefits against alcohol-induced oxidative damage and inflammation, promoting bone health. This study investigates the effects of zingerone on markers of bone turnover and morphometry in neonatal rats subjected to alcohol exposure during critical developmental stages.
methodsTen-day-old male Sprague-Dawley rats (N = 35) were randomized and treated with water (C), zingerone (Z) (40 mg/kg), alcohol (A) (1 g/kg) or zingerone-alcohol combination (ZA) for 9 days. During adolescence, rats received either water or a secondary A insult (20% v/v) for 54 days. At termination, ELISA kits were used to measure biomarkers of bone formation (bone-specific alkaline phosphatase, osteocalcin, and procollagen Type I N-terminal propeptide). Bone morphology and morphometry was assessed using microcomputed tomography.
resultsNeonatal zingerone (Z + A; ZA + A) and double alcohol exposure (A + A) significantly increased plasma BALP and P1NP levels (p < 0.05). Tibial length remained unchanged across groups (p > 0.05). Neonatal zingerone with adolescent alcohol (Z + A) significantly reduced tibial mass, bone mass-to-length ratios, and trabecular architecture near the growth plate (p < 0.05). Neonatal and adolescent administration of alcohol (A + A) significantly increased midshaft cortical thickness (p < 0.05).
conclusionAdolescent alcohol treatment impaired bone function and morphology, neonatal zingerone alone offering limited protection. Coadministration of zingerone with alcohol neonatally produced variable and context-dependent changes with no clear evidence of sustained protection against the effects of alcohol exposure. These findings underscore the importance of optimizing timing, dosage, and combination therapies for bone health. Further studies are warranted to clarify whether zingerone has clinically meaningful bone-protective effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.